Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging

OBJECTIVES: The purpose of this study was to carefully analyse the therapeutic benefit of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) and cardiomyopathy (ATTRwt-CM) after one year of therapy based on serial multi-parametric cardiovascular magnetic resonance (CMR) imaging....

Descripción completa

Detalles Bibliográficos
Autores principales: Chamling, Bishwas, Bietenbeck, Michael, Korthals, Dennis, Drakos, Stefanos, Vehof, Volker, Stalling, Philipp, Meier, Claudia, Yilmaz, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998574/
https://www.ncbi.nlm.nih.gov/pubmed/35666277
http://dx.doi.org/10.1007/s00392-022-02035-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998574/
https://www.ncbi.nlm.nih.gov/pubmed/35666277
http://dx.doi.org/10.1007/s00392-022-02035-w

Ejemplares similares